Miller AH - Search Results

1

Promoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findings.

Yoshida K, Alagbe O, Wang X, Woolwine B, Thornbury M, Raison CL, Miller AH. Yoshida K, et al. Among authors: miller ah. Neuropsychobiology. 2005;52(2):55-61. doi: 10.1159/000086605. Epub 2005 Jun 29. Neuropsychobiology. 2005. PMID: 15990456

2

Double jeopardy: schizophrenia and substance use.

Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance R. Swofford CD, et al. Among authors: miller ah. Am J Drug Alcohol Abuse. 2000 Aug;26(3):343-53. doi: 10.1081/ada-100100248. Am J Drug Alcohol Abuse. 2000. PMID: 10976661

3

The neuroimmunology of stress and depression.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Semin Clin Neuropsychiatry. 2001 Oct;6(4):277-94. doi: 10.1053/scnp.2001.0060277. Semin Clin Neuropsychiatry. 2001. PMID: 11607923

4

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH. Capuron L, et al. Among authors: miller ah. Neuropsychopharmacology. 2002 May;26(5):643-52. doi: 10.1016/S0893-133X(01)00407-9. Neuropsychopharmacology. 2002. PMID: 11927189 Clinical Trial.

5

Increased early life stress and depressive symptoms in patients with comorbid substance abuse and schizophrenia.

Scheller-Gilkey G, Thomas SM, Woolwine BJ, Miller AH. Scheller-Gilkey G, et al. Among authors: miller ah. Schizophr Bull. 2002;28(2):223-31. doi: 10.1093/oxfordjournals.schbul.a006933. Schizophr Bull. 2002. PMID: 12693429

6

Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH. Capuron L, et al. Among authors: miller ah. Am J Psychiatry. 2003 Jul;160(7):1342-5. doi: 10.1176/appi.ajp.160.7.1342. Am J Psychiatry. 2003. PMID: 12832253 Clinical Trial.

7

Depression in cancer: new developments regarding diagnosis and treatment.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Biol Psychiatry. 2003 Aug 1;54(3):283-94. doi: 10.1016/s0006-3223(03)00413-x. Biol Psychiatry. 2003. PMID: 12893104 Review.

8

[Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].

Capuron L, Dantzer R, Miller AH. Capuron L, et al. Among authors: miller ah. J Soc Biol. 2003;197(2):151-6. J Soc Biol. 2003. PMID: 12910630 Review. French.

9

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.

Raison CL, Miller AH. Raison CL, et al. Among authors: miller ah. Am J Psychiatry. 2003 Sep;160(9):1554-65. doi: 10.1176/appi.ajp.160.9.1554. Am J Psychiatry. 2003. PMID: 12944327 Review.

10

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics.

Scheller-Gilkey G, Woolwine BJ, Cooper I, Gay O, Moynes KA, Miller AH. Scheller-Gilkey G, et al. Among authors: miller ah. Am J Drug Alcohol Abuse. 2003 Aug;29(3):553-66. doi: 10.1081/ada-120023458. Am J Drug Alcohol Abuse. 2003. PMID: 14510040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page